Literature DB >> 11301585

Highlights of human toxocariasis.

J F Magnaval1, L T Glickman, P Dorchies, B Morassin.   

Abstract

Human toxocariasis is a helminthozoonosis due to the migration of Toxocara species larvae through human organism. Humans become infected by ingesting either embryonated eggs from soil (geophagia, pica), dirty hands or raw vegetables, or larvae from undercooked giblets. The diagnosis relies upon sensitive immunological methods (ELISA or western-blot) which use Toxocara excretory-secretory antigens. Seroprevalence is high in developed countries, especially in rural areas, and also in some tropical islands. The clinical spectrum of the disease comprises four syndromes, namely visceral larva migrans, ocular larva migrans, and the more recently recognized "common" (in adults) and "covert" (in children) pictures. Therapy of ocular toxocariasis is primarily based upon corticosteroids use, when visceral larva migrans and few cases of common or covert toxocariasis can be treated by anthelmintics whose the most efficient appeared to be diethylcarbamazine. When diagnosed, all of these syndromes require thorough prevention of recontamination (especially by deworming pets) and sanitary education.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11301585      PMCID: PMC2721060          DOI: 10.3347/kjp.2001.39.1.1

Source DB:  PubMed          Journal:  Korean J Parasitol        ISSN: 0023-4001            Impact factor:   1.341


  70 in total

1.  Chronic eosinophilia due to visceral larva migrans; report of three cases.

Authors:  P C BEAVER; C H SNYDER; G M CARRERA; J H DENT; J W LAFFERTY
Journal:  Pediatrics       Date:  1952-01       Impact factor: 7.124

2.  Nematode endophthalmitis.

Authors:  H C WILDER
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1950 Nov-Dec

3.  Transmission of toxocariasis.

Authors:  D Stürchler; N Weiss; M Gassner
Journal:  J Infect Dis       Date:  1990-08       Impact factor: 5.226

4.  [Comparative efficacy of thiabendazole and mebendazole in the treatment of toxocariasis].

Authors:  J F Magnaval; J P Charlet
Journal:  Therapie       Date:  1987 Oct-Dec       Impact factor: 2.070

5.  Detection of Toxocara by computed tomography.

Authors:  B Dupas; J Barrier; P Barre
Journal:  Br J Radiol       Date:  1986-05       Impact factor: 3.039

6.  Ultrasound findings in children with toxocariasis: report on 18 cases.

Authors:  M Baldisserotto; C F Conchin; M da G Soares; M A Araujo; B Kramer
Journal:  Pediatr Radiol       Date:  1999-05

Review 7.  A critical look at the importance, prevalence and control of toxocariasis and the possibilities of immunological control.

Authors:  O O Barriga
Journal:  Vet Parasitol       Date:  1988-09       Impact factor: 2.738

8.  Epidemiology of human toxocariasis in La Réunion.

Authors:  J F Magnaval; A Michault; N Calon; J P Charlet
Journal:  Trans R Soc Trop Med Hyg       Date:  1994 Sep-Oct       Impact factor: 2.184

9.  Application of the western blotting procedure for the immunodiagnosis of human toxocariasis.

Authors:  J F Magnaval; R Fabre; P Maurières; J P Charlet; B de Larrard
Journal:  Parasitol Res       Date:  1991       Impact factor: 2.289

10.  Human Toxocara infection of the central nervous system and neurological disorders: a case-control study.

Authors:  J F Magnaval; V Galindo; L T Glickman; M Clanet
Journal:  Parasitology       Date:  1997-11       Impact factor: 3.234

View more
  120 in total

1.  CT and MR imaging findings in cerebral toxocaral disease.

Authors:  E Xinou; A Lefkopoulos; M Gelagoti; A Drevelegas; A Diakou; I Milonas; A S Dimitriadis
Journal:  AJNR Am J Neuroradiol       Date:  2003-04       Impact factor: 3.825

2.  Toxocara-infestations in Austria: a study on the risk of infection of farmers, slaughterhouse staff, hunters and veterinarians.

Authors:  Armin Deutz; Klemens Fuchs; Herbert Auer; Ulrike Kerbl; Horst Aspöck; Josef Köfer
Journal:  Parasitol Res       Date:  2005-09-07       Impact factor: 2.289

3.  Coprological study on intestinal helminths in Swiss dogs: temporal aspects of anthelminthic treatment.

Authors:  H Sager; Ch Steiner Moret; F Grimm; P Deplazes; M G Doherr; B Gottstein
Journal:  Parasitol Res       Date:  2005-12-22       Impact factor: 2.289

4.  Development and evaluation of a sensitive and specific assay for diagnosis of human toxocariasis by use of three recombinant antigens (TES-26, TES-30USM, and TES-120).

Authors:  Suharni Mohamad; Norhaida Che Azmi; Rahmah Noordin
Journal:  J Clin Microbiol       Date:  2009-04-15       Impact factor: 5.948

5.  Assessment of the diagnostic value of specific anti-Toxocara IgA in Slovakian patients suspected to have toxocarosis.

Authors:  Vojtech Boldiš; František Ondriska; Simona Lipková
Journal:  Folia Microbiol (Praha)       Date:  2017-12-06       Impact factor: 2.099

6.  Histopathologic changes and larval recovery of Toxocara cati in experimentally infected chickens.

Authors:  S Azizi; A Oryan; S M Sadjjadi; M Zibaei
Journal:  Parasitol Res       Date:  2007-09-03       Impact factor: 2.289

7.  Enteroparasitoses and Toxocarosis Affecting Children from Mar del Plata City, Argentina.

Authors:  Carla Lavallén; Beatriz Brignani; Karina Riesgo; Amalia Rojas; Gabriela Colace; Martín Biscaychipi; Estela Chicote; Cristian Giuntini; Mariela Kifer; María Eugenia Del Río; Guillermo Denegri; Marcela Dopchiz
Journal:  Ecohealth       Date:  2017-04-21       Impact factor: 3.184

8.  Human Toxocariasis: Prevalence and Factors Associated with Biosafety in Research Laboratories.

Authors:  Gabriela Torres Mattos; Paula Costa Dos Santos; Paula de Lima Telmo; Maria Elisabeth Aires Berne; Carlos James Scaini
Journal:  Am J Trop Med Hyg       Date:  2016-10-03       Impact factor: 2.345

9.  Ultrastructural localization of Toxocara canis larval antigen reacted with a seropositive human serum.

Authors:  Soo-Ung Lee; Jae-Ran Yu; Sun Huh
Journal:  Korean J Parasitol       Date:  2009-03-12       Impact factor: 1.341

10.  Seroprevalence of Toxocara antibodies among patients suspected of ocular toxocariasis in Slovenia.

Authors:  Jernej Logar; Barbara Soba; Aleksandra Kraut; Branka Stirn-Kranjc
Journal:  Korean J Parasitol       Date:  2004-09       Impact factor: 1.341

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.